No programs found.
Migraine affects between 11% and 16% of adults in the United States. This condition is associated with a significant societal and economic burden. There are many pharmacologic and nonpharmacologic treatment options for both chronic and episodic migraine, and clinicians should tailor these therapies to individual patient characteristics as well as disease severity and patterns. Additionally, patien ...
Migraine affects between 11% and 16% of adults in the United States. This condition is associated with a significant societal and economic burden. On an individual level, chronic migraine is associated with reduced health-related quality of life and increased psychiatric and medical comorbidities. Guidelines provide definitions and diagnostic criteria for types of migraine and can aid clinicians i ...
Multiple sclerosis (MS) is a chronic neurologic disorder with potential for substantial negative impact on quality of life. MS is nearly 3 times more common in women compared with men and is typically diagnosed between the ages of 20 and 50. Since the diagnosis and treatment of MS frequently occur during women’s reproductive years, clinicians often face questions about MS treatment as it relates t ...
- Video Roundtable